This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Malcolm Keith Brenner: Innovator in Genetic Engineering
Introduction
Malcolm Keith Brenner is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of genetic engineering, particularly through his innovative work with herpes virus vectors. His research focuses on the introduction of heterologous genetic material into human and non-human animal cells.
Latest Patents
Brenner holds a patent for "Herpes virus vectors and their uses." This patent describes a process for treating cells to introduce genetic material, which involves using a recombinant herpesviral vector that is attenuated or replication-defective. The method allows for the transduction of various cell types, including hemopoietic and malignant cells, to express the introduced genetic material. This technique has potential applications in modifying hemopoietic cells and generating tumor immunogens from malignant cells.
Career Highlights
Throughout his career, Brenner has focused on advancing the understanding and application of genetic engineering techniques. His work has contributed to the development of innovative therapies that leverage viral vectors for gene therapy. His expertise in this area has positioned him as a key figure in the field.
Collaborations
Brenner has collaborated with notable colleagues, including Michael Edward Griffith Boursnell and Stephen Charles Inglis. These partnerships have fostered a collaborative environment that enhances research and innovation in genetic engineering.
Conclusion
Malcolm Keith Brenner's contributions to genetic engineering through his patent on herpes virus vectors exemplify the potential of innovative approaches in medicine. His work continues to influence the field and pave the way for future advancements in gene therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile